Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers
Clinical trial NCT03801915 · COMPLETED
Trial details
- NCT number
- NCT03801915
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-13
- Primary completion
- 2022-05-27
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.